Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 157

1.

Amikacin-fosfomycin at a five-to-two ratio: characterization of mutation rates in microbial strains causing ventilator-associated pneumonia and interactions with commonly used antibiotics.

Montgomery AB, Rhomberg PR, Abuan T, Walters KA, Flamm RK.

Antimicrob Agents Chemother. 2014 Jul;58(7):3708-13. doi: 10.1128/AAC.02779-13. Epub 2014 Apr 21.

2.

Potentiation effects of amikacin and fosfomycin against selected amikacin-nonsusceptible Gram-negative respiratory tract pathogens.

Montgomery AB, Rhomberg PR, Abuan T, Walters KA, Flamm RK.

Antimicrob Agents Chemother. 2014 Jul;58(7):3714-9. doi: 10.1128/AAC.02780-13. Epub 2014 Apr 21.

3.

Synergy of fosfomycin with other antibiotics for Gram-positive and Gram-negative bacteria.

Kastoris AC, Rafailidis PI, Vouloumanou EK, Gkegkes ID, Falagas ME.

Eur J Clin Pharmacol. 2010 Apr;66(4):359-68. doi: 10.1007/s00228-010-0794-5. Epub 2010 Feb 26.

PMID:
20186407
4.

In vitro activities of antibiotic combinations against clincal isolates of Pseudomonas aeruginosa.

Chen YH, Peng CF, Lu PL, Tsai JJ, Chen TP.

Kaohsiung J Med Sci. 2004 Jun;20(6):261-7.

PMID:
15253466
5.

[Mechanism of drug resistance of carbapenems-resistant Acinetobacter baumannii and the application of a combination of drugs in vitro].

Zhao C, Xie W, Zhang W, Ye Z, Wu H.

Zhonghua Shao Shang Za Zhi. 2014 Apr;30(2):166-70. Chinese.

PMID:
24989663
6.
7.

In vitro activity of ceftaroline alone and in combination against clinical isolates of resistant gram-negative pathogens, including beta-lactamase-producing Enterobacteriaceae and Pseudomonas aeruginosa.

Vidaillac C, Leonard SN, Sader HS, Jones RN, Rybak MJ.

Antimicrob Agents Chemother. 2009 Jun;53(6):2360-6. doi: 10.1128/AAC.01452-08. Epub 2009 Apr 6.

8.

Antibacterial activities of a fosfomycin/tobramycin combination: a novel inhaled antibiotic for bronchiectasis.

MacLeod DL, Barker LM, Sutherland JL, Moss SC, Gurgel JL, Kenney TF, Burns JL, Baker WR.

J Antimicrob Chemother. 2009 Oct;64(4):829-36. doi: 10.1093/jac/dkp282. Epub 2009 Aug 13.

9.

Activity of amikacin, ertapenem, ciprofloxacin and levofloxacin alone and in combination against resistant nosocomial pathogens by time-kill.

Hosgor-Limoncu M, Ermertcan S, Tasli H, Yurtman AN.

West Indian Med J. 2008 Mar;57(2):106-11.

PMID:
19565951
10.
11.

Resistance development of cystic fibrosis respiratory pathogens when exposed to fosfomycin and tobramycin alone and in combination under aerobic and anaerobic conditions.

McCaughey G, Diamond P, Elborn JS, McKevitt M, Tunney MM.

PLoS One. 2013 Jul 25;8(7):e69763. doi: 10.1371/journal.pone.0069763. Print 2013.

12.

In vitro activities of cefepime alone and with amikacin against aminoglycoside-resistant gram-negative bacteria.

Fung-Tomc J, Huczko E, Kolek B, Thater C, Kessler RE.

Antimicrob Agents Chemother. 1991 Dec;35(12):2652-4.

13.
14.

Cell-wall-inhibiting antibiotic combinations with activity against multidrug-resistant Klebsiella pneumoniae and Escherichia coli.

Hickman RA, Hughes D, Cars T, Malmberg C, Cars O.

Clin Microbiol Infect. 2014 Apr;20(4):O267-73. doi: 10.1111/1469-0691.12374. Epub 2013 Oct 2.

15.
16.
17.

In vitro activities of ureidopenicillins alone and in combination with amikacin and three cephalosporin antibiotics.

Moody JA, Peterson LR, Gerding DN.

Antimicrob Agents Chemother. 1984 Aug;26(2):256-9.

18.

Empiric antibiotics pending bronchoalveolar lavage data in patients without pneumonia significantly alters the flora, but not the resistance profile, if a subsequent pneumonia develops.

Thakkar RK, Monaghan SF, Adams CA Jr, Stephen A, Connolly MD, Gregg S, Cioffi WG, Heffernan DS.

J Surg Res. 2013 May;181(2):323-8. doi: 10.1016/j.jss.2012.07.021. Epub 2012 Jul 26.

PMID:
22906560
19.

In vitro activity effects of twelve antibiotics alone and in association against twenty-seven Enterococcus faecalis strains isolated from Italian patients with infective endocarditis: high in vitro synergistic effect of the association ceftriaxone-fosfomycin.

Farina C, Russello G, Chinello P, Pasticci MB, Raglio A, Ravasio V, Rizzi M, Scarparo C, Vailati F, Suter F; Italian Infective Endocarditis Study Group (SEI).

Chemotherapy. 2011;57(5):426-33. doi: 10.1159/000330458. Epub 2011 Nov 26.

PMID:
22122863
20.

Supplemental Content

Support Center